发明授权
US08569493B2 Method for treating a homeostasis-related disease or glaucoma by administering a 1,2,3,4-tetrahyroquinoxaline compound
失效
通过施用1,2,3,4-四氢喹喔啉化合物治疗体内平衡相关疾病或青光眼的方法
- 专利标题: Method for treating a homeostasis-related disease or glaucoma by administering a 1,2,3,4-tetrahyroquinoxaline compound
- 专利标题(中): 通过施用1,2,3,4-四氢喹喔啉化合物治疗体内平衡相关疾病或青光眼的方法
-
申请号: US13364680申请日: 2012-02-02
-
公开(公告)号: US08569493B2公开(公告)日: 2013-10-29
- 发明人: Mamoru Matsuda , Toshiyuki Mori , Masato Nagatsuka , Sachiko Kobayashi , Masatomo Kato , Miwa Takai
- 申请人: Mamoru Matsuda , Toshiyuki Mori , Masato Nagatsuka , Sachiko Kobayashi , Masatomo Kato , Miwa Takai
- 申请人地址: JP Osaka
- 专利权人: Santen Pharmaceutical Co., Ltd.
- 当前专利权人: Santen Pharmaceutical Co., Ltd.
- 当前专利权人地址: JP Osaka
- 代理机构: Holtz, Holtz, Goodman & Chick PC
- 优先权: JP2007-141568 20070529
- 主分类号: C07D471/00
- IPC分类号: C07D471/00
摘要:
A method for preventing or treating a metabolic disorder, an inflammatory disease, an autoimmune disease, an allergic disease, a central nervous system disease, a cardiovascular disease, a homeostasis-related disease or glaucoma, involving administering a compound or a salt thereof, the compound having the following formula (1): wherein R1 represents alkyl, cycloalkyl, aryl, heterocyclic or aralkyl; R7 represents cycloalkyl, aryl or heterocyclic; W represents oxygen or NR8, Y represents alkylene, Z represents oxygen, sulfur, OCO or NR9; R2, R3, R4, R6, R8 and R9 represent hydrogen or alkyl.
公开/授权文献
信息查询